Conversely, G3335-induced PPAR- γ block does not alter the expression of another major peroxisome protein, PMP70, a membrane protein possessing multiple peroxisome-targeting signals [ 48].
Blocking p53 did not alter drug-induced senescence in Hs294T or SK-Mel-28 cells (Fig 2F), indicating that p53 is not required for MLN8237-induced senescence.
STAT3C-mediated hyporesponsiveness was independent of STAT3C-induced IL-10 (see below), because neutralization of IL-10 by blocking antibodies did not alter proliferation of STAT3C-transgenic T cells after anti-CD3/anti-CD28 stimulation (n = 3, P < 0.001; Supplemental Fig. S1).
Co-administration of a UNC5B blocking antibody did not alter netrin-1-mediated protection, with mice exhibiting no differences in weight loss, colon length or histologic injury to those treated with control IgG (figure 8A C), thus indicating that netrin-1 was not acting through UNC5B to protect in DSS.
Paradoxically, we have shown previously that DAPT treatment of whole embryos completely blocked cHairy2, but did not alter Foxa2 expression (Gray and Dale, 2010), whereas we show here that DAPT treatment of I-LNPs blocks Shh induction of both cHairy2 and Foxa2.
Although PAI-1 can alter cell motility by competing for a common binding site on vitronectin, blocking this site did not alter the motility rate.
Since blocking synaptic transmission did not alter the 5-HT regulation of AP firing, the opposing effects of 5-HT1A and 5-HT2 oneuronalal excitability could be attributable to their coupling to distinct ion channels including various K+, Ca2+, or cation channels [48] [51].
Further, we found that NKp30 is expressed in significantly lower levels among NK cells of metastatic melanoma patients as compared to healthy donors (Figure 6), and consequently that blocking of NKp30 did not alter the anti melanoma function of these NK cells (Figure 9E).
Sulfonation (N-, 3- O and 6- O) significantly augmented this effect by blocking pseudorotation, but did not alter the rotational preferences of hydroyxl or hydroxymethyl groups.
Using anti-phospho-specific Bad (Ser122) and Bad (Ser136) antibodies, we observed that blocking MEK1/2 activity did not alter the levels of Bad phosphorylation at Serine 112 and Serine 136 (data not shown).
